Sciendo Logo
  1. bookVolume 21 (2013): Issue 2 (June 2013)
Revista Romana de Medicina de Laborator's Cover Image
Revista Romana de Medicina de Laborator
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Reciprocal antagonism between inflammation and the protein C system

Mircea Cucuianu
Ioana Brudasca
Luminita Plesca
Gyorgy Bodizs
Dan Colhon
Andrei Cucuianu
Published Online: 21 Jun 2013
Page range: 129 - 133
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Protein C is a vitamin K-dependent serine protease secreted by the hepatocytes as an inactive zymogen and activated by thrombin bound to endothelial thrombomodulin. An endothelial protein C receptor (EPCR) is involved in both activation and enhancement of protein C activity, resulting in proteolytic degradation of clotting factors Va and VIIIa, thereby providing an efficient anticoagulant mechanism. Evidence was also provided that proinflammatory cytokines would impair the endothelia-mediated activation and activity of the Protein C system by inducing an internalization and proteolytic degradation of thrombomodulin and by shedding EPCR from the surface of endothelial cells membrane. Clinical and experimental studies also emphasized that an inflammatory acute phase reaction is accompanied by a commuted hepatic protein synthesis leading to an increase of plasma fibrinogen, factor VIII:C and of α1 protease inhibitor, while the plasma level of protein C zymogen decrease. On the other hand infusions of activated protein C were reported to protect from a toxico-septic shock by exerting not only anticoagulant but also anti-inflammatory effects.

Keywords

  • Protein C
  • thrombomodulin
  • endothelial protein C receptor
  • inflammation-dependent depressive effects
  • therapeutic approach with activated protein C

Cuvinte cheie

  • proteina C
  • trombomodulina
  • receptor endotelial al proteinei C
  • efecte depresive ale inflamaţiei
  • abordare terapeutică prin infuzii cu Proteina C activată

1. Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15;314(20):1298-134.10.1056/NEJM198605153142006Search in Google Scholar

2. Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994 Oct 21;269(42):26486-9110.1016/S0021-9258(18)47220-1Search in Google Scholar

3. Esmon CT. The protein C pathway. Chest. 2003 Sep;124(3 Suppl):26S-32S10.1378/chest.124.3_suppl.26SSearch in Google Scholar

4. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 1989 Jan;73(1):159-65.10.1182/blood.V73.1.159.159Search in Google Scholar

5. Xu J, Qu D, Esmon NL, Esmon CT. Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem. 2000 Feb 25;275(8):6038-4410.1074/jbc.275.8.6038Search in Google Scholar

6. Kurosawa S, Stearns DJ, Carson CW, D’Angello A, Della Valle P, Esmon CT. Plasma levels of endothelial protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 1998;91:725-72710.1182/blood.V91.2.725Search in Google Scholar

7. Cucuianu A, Brudaşcă I, Colhon D, Paţiu M, Basarab C, Cucuianu M. Plasma protein C and antithrombin III in patients with acute leukemia. Rom J Intern Med. 1994 Jul- Sep;32(3):209-14.Search in Google Scholar

8. Cucuianu M, Brudasca I, Trif I, Stancu A. Clinical studies on plasma protein C. Correlation with serum cholinesterase. Nouv Rev Fr Hematol. 1993;35(5):481-6.Search in Google Scholar

9. Samis JA, Stewart KA, Nesheim ME, Taylor FB Jr. Time-dependent association between coagulation factor inactivation and increased elastase during experimental sepsis. J Thromb Haemost. 2009 Jun;7(6):1032-410.1111/j.1538-7836.2009.03347.xSearch in Google Scholar

10. Plesca L, Brudasca I, Colhon D, Cucuianu M. Hemostatic balance during the acute inflammatory reaction. (II). With special reference to plasma protein C. Rom J Physiol. 1995 Jan-Dec;32(1-4):35-8.Search in Google Scholar

11. van der Meer FJ, van Tilburg NH, van Wijngaarden A, van der Linden IK, Briët E, Bertina RM. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin. Thromb Haemost. 1989 Sep 29;62(2):756-62.10.1055/s-0038-1646897Search in Google Scholar

12. Hoffman M, Fuchs HE, Pizzo SV. The macrophagemediated regulation of hepatocyte synthesis of antithrombin III and alpha 1-proteinase inhibitor. Thromb Res. 1986 Mar 1;41(5):707-15.10.1016/0049-3848(86)90368-3Search in Google Scholar

13. Werner M. Serum protein changes during the acute phase reaction. Clin Chim Acta. 1969 Aug;25(2):299-30510.1016/0009-8981(69)90272-1Search in Google Scholar

14. Taylor FB Jr, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987 Mar;79(3):918-25.10.1172/JCI112902Search in Google Scholar

15. Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, Casey W. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet. 1997 Nov 29;350(9091):1590-3.10.1016/S0140-6736(97)06356-3Search in Google Scholar

16. Grey ST, Tsushida A, Hau H, Orthner CC, Salem H, Hancock WW. Selective inhibiting effects of anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ and phorbal ester. J Immunol 1994;15(8):3664-3672Search in Google Scholar

17. Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation. 1995 Dec 27;60(12):1525-32.10.1097/00007890-199560120-00026Search in Google Scholar

18. Frolich M, Doring A, Imhofa, Hutchinson WL, Pepys MB, Koenig W. Oral contraceptives use is associated with a systemic acute phase reaction. Fibrinolysis and proteolysis. 1999; 13(6):239-24410.1054/fipr.1999.0037Search in Google Scholar

19. Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, Rosendaal FR. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood. 2012 Feb 9;119(6):1555-60.10.1182/blood-2011-09-380618Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo